Taiwan FDA registration 903118cda4abeef833aca9714d00ba89
Longteng cardiomyocardin in vitro reagent card (serum)
TW: 龍騰心肌素體外試劑卡(血清)
Taiwan·Risk Class 2·The first factory of Longteng Biotechnology Co., Ltd·Registered Dec 07, 2006 – Dec 07, 2016CancelledRegistration details
- Analysis ID
- 903118cda4abeef833aca9714d00ba89
- Customs Code
- DHY00500228903
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- The first factory of Longteng Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of Troponin I antibodies in human serum.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- Dec 07, 2006
- Expiry Date
- Dec 07, 2016
- Cancellation Date
- Dec 13, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Longteng cardiomyocardin in vitro reagent card (serum) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 903118cda4abeef833aca9714d00ba89 and manufactured by The first factory of Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is The first factory of Longteng Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices